{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:22:31Z","timestamp":1788283351283,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberous sclerosis complex (TSC) is a rare, autosomal dominant genetic disease that arises from <jats:italic>TSC1<\/jats:italic> or <jats:italic>TSC2<\/jats:italic> genetic mutations. These genetic mutations can induce the development of benign tumors in any organ system with significant clinical implications in morbidity and mortality. In rare instances, patients with TSC can have malignant tumors, including renal cell carcinoma (RCC) and pancreatic neuroendocrine tumor (PNET). It is considered a hereditary renal cancer syndrome despite the low incidence of RCC in TSC patients. TSC is typically diagnosed in prenatal and pediatric patients and frequently associated with neurocognitive disorders and seizures, which are often experienced early in life. However, penetrance and expressivity of <jats:italic>TSC<\/jats:italic> mutations are highly variable. Herein, we present a case report, with associated literature, to highlight that there exist undiagnosed adult patients with less penetrant features, whose clinical presentation may contain non-classical signs and symptoms, who have pathogenic <jats:italic>TSC<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 31-year-old female with past medical history of leiomyomas status post myomectomy presented to the emergency department for a hemorrhagic adnexal cyst. Imaging incidentally identified a renal mass suspicious for RCC. Out of concern for hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome, the mass was surgically removed and confirmed as RCC. Discussion with medical genetics ascertained a family history of kidney cancer and nephrectomy procedures and a patient history of ungual fibromas on the toes. Genetic testing for hereditary kidney cancer revealed a 5\u2019UTR deletion in the <jats:italic>TSC1<\/jats:italic> gene, leading to a diagnosis of TSC. Following the diagnosis, dermatology found benign skin findings consistent with TSC. About six months after the incidental finding of RCC, a PNET in the pancreatic body\/tail was incidentally found on chest CT imaging, which was removed and determined to be a well-differentiated PNET. Later, a brain MRI revealed two small cortical tubers, one in each frontal lobe, that were asymptomatic; the patient\u2019s history and family history did not contain seizures or learning delays. The patient presently shows no evidence of recurrence or metastatic disease, and no additional malignant tumors have been identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To our knowledge, this is the first report in the literature of a TSC patient without a history of neurocognitive disorders with RCC and PNET, both independently rare occurrences in TSC. The patient had a strong family history of renal disease, including RCC, and had several other clinical manifestations of TSC, including skin and brain findings. The incidental finding and surgical removal of RCC prompted the genetic evaluation and diagnosis of TSC, leading to a comparably late diagnosis for this patient. Reporting the broad spectrum of disease for TSC, including more malignant phenotypes such as the one seen in our patient, can help healthcare providers better identify patients who need genetic evaluation and additional medical care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01913-8","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:02:08Z","timestamp":1716800528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Malignant tumors in tuberous sclerosis complex: a case report and review of the literature"],"prefix":"10.1186","volume":"17","author":[{"given":"Cassie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh M.","family":"Lele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Goodenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn M.","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Padussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"issue":"13","key":"1913_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"1","key":"1913_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","volume":"50","author":"J Borkowska","year":"2011","unstructured":"Borkowska J, Schwartz RA, Kotulska K, Jozwiak S. Tuberous sclerosis complex: tumors and tumorigenesis. Int J Dermatol. 2011;50(1):13\u201320.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1913_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1590\/1678-4685-gmb-2015-0321","volume":"40","author":"C Rosset","year":"2017","unstructured":"Rosset C, Netto CBO, Ashton-Prolla P. TSC1 and TSC2 gene mutations and their implications for treatment in tuberous sclerosis complex: a review. Genet Mol Biol. 2017;40(1):69\u201379.","journal-title":"Genet Mol Biol"},{"key":"1913_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50\u201366.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1913_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.acra.2020.12.019","volume":"29","author":"S Gupta","year":"2022","unstructured":"Gupta S, Kang HC, Faria SC, Choyke PL, Kundra V. Tuberous sclerosis complex (TSC): renal and extrarenal imaging. Acad Radiol. 2022;29(3):439\u201349.","journal-title":"Acad Radiol"},{"key":"1913_CR6","unstructured":"Ekong R. The TSC1 gene homepage: Global Variome; [ https:\/\/databases.lovd.nl\/shared\/genes\/TSC1."},{"key":"1913_CR7","unstructured":"Ekong R. The TSC2 gene homepage: Global Variome; [ https:\/\/databases.lovd.nl\/shared\/genes\/TSC2."},{"issue":"5","key":"1913_CR8","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, et al. Comprehensive mutation analysis of TSC1and TSC2\u2014and phenotypic correlations in 150 families with tuberous sclerosis. Am J HumGenet. 1999;64(5):1305\u201315.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1913_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2,\u2009compared with TSC1,\u2009Disease in multiple organs. Am J Hum Genet. 2001;68(1):64\u201380.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1913_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2014 a contiguous gene syndrome. Nat Genet. 1994;8(4):328\u201332.","journal-title":"Nat Genet"},{"key":"1913_CR11","doi-asserted-by":"crossref","unstructured":"Orosz P, Koll\u00e1k Z, Peth\u0151 \u00c1, Fogarasi A, Reusz G, Hadzsiev K et al. The importance of genetic testing in the differential diagnosis of atypical TSC2-PKD1 contiguous gene syndrome-case series. Children (Basel). 2023;10(3):420.","DOI":"10.3390\/children10030420"},{"issue":"1","key":"1913_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13023-021-01917-y","volume":"16","author":"M Sauter","year":"2021","unstructured":"Sauter M, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet J Rare Dis. 2021;16(1):301.","journal-title":"Orphanet J Rare Dis."},{"issue":"12","key":"1913_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.7150\/jca.14747","volume":"7","author":"SL Habib","year":"2016","unstructured":"Habib SL, Al-Obaidi NY, Nowacki M, Pietkun K, Zegarska B, Kloskowski T, et al. Is mTOR inhibitor good enough for treatment all tumors in TSC patients? J Cancer. 2016;7(12):1621\u201331.","journal-title":"J Cancer."},{"key":"1913_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.humpath.2022.09.001","volume":"129","author":"S Gupta","year":"2022","unstructured":"Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, et al. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Hum Pathol. 2022;129:123\u201339.","journal-title":"Hum Pathol."},{"issue":"2","key":"1913_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4158\/EP.8.2.109","volume":"8","author":"MS Eledrisi","year":"2002","unstructured":"Eledrisi MS, Stuart CA, Alshanti M. Insulinoma in a patient with tuberous sclerosis: is there an association? Endocr Pract. 2002;8(2):109\u201312.","journal-title":"Endocr Pract"},{"issue":"6","key":"1913_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1399-0004.2011.01805.x","volume":"82","author":"A Larson","year":"2012","unstructured":"Larson A, Hedgire S, Deshpande V, Stemmer-Rachamimov A, Harisinghani M, Ferrone C, et al. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clin Genet. 2012;82(6):558\u201363.","journal-title":"Clin Genet"},{"issue":"1","key":"1913_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00247-016-3701-0","volume":"47","author":"G Koc","year":"2017","unstructured":"Koc G, Sugimoto S, Kuperman R, Kammen BF, Karakas SP. Pancreatic tumors in children and young adults with tuberous sclerosis complex. Pediatr Radiol. 2017;47(1):39\u201345.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"1913_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1210\/js.2019-00051","volume":"3","author":"S Mehta","year":"2019","unstructured":"Mehta S, Rusyn L, Ginsburg H, Hajdu C, Kohn B. Pancreatic neuroendocrine tumor in a young child with tuberous sclerosis complex 1. J Endocr Soc. 2019;3(6):1201\u20136.","journal-title":"J Endocr Soc"},{"issue":"9","key":"1913_CR19","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/ajmg.a.62850","volume":"188","author":"LM Evans","year":"2022","unstructured":"Evans LM, Geenen KR, O\u2019Shea A, Hedgire SS, Ferrone CR, Thiele EA. Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: management and surgical outcomes. Am J Med Genet Part A. 2022;188(9):2666\u201371.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"1913_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","volume":"21","author":"NB Haas","year":"2014","unstructured":"Haas NB, Nathanson KL. Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis. 2014;21(1):81\u201390.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"1913_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol. 2018;14(11):704\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"1913_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.fertnstert.2011.06.038","volume":"96","author":"AM Taveira-Dasilva","year":"2011","unstructured":"Taveira-Dasilva AM, Rabel A, Gochuico BR, Avila NA, Moss J. Prevalence of uterine leiomyomas in lymphangioleiomyomatosis. Fertil Steril. 2011;96(3):711\u2013e41.","journal-title":"Fertil Steril"},{"issue":"9","key":"1913_CR23","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1210\/me.2013-1059","volume":"27","author":"H Prizant","year":"2013","unstructured":"Prizant H, Sen A, Light A, Cho S-N, DeMayo FJ, Lydon JP, et al. Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs. Mol Endocrinol. 2013;27(9):1403\u201314.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"1913_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12032-019-1297-6","volume":"36","author":"JM Kennedy","year":"2019","unstructured":"Kennedy JM, Wang X, Plouffe KR, Dhanasekaran SM, Hafez K, Palapattu GS, et al. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series. Med Oncol. 2019;36(9):74.","journal-title":"Med Oncol"},{"issue":"173","key":"1913_CR25","first-page":"205","volume":"34","author":"S Singh","year":"2022","unstructured":"Singh S, Chaurasia A, Gopal N, Malayeri A, Ball MW. Treatment strategies for hereditary kidney cancer: current recommendations and updates. Discov Med. 2022;34(173):205\u201320.","journal-title":"Discov Med"},{"issue":"1","key":"1913_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/ERC-08-0142","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Grossman AB. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocrine Related Cancer. 2009;16(1):45\u201358.","journal-title":"Endocrine-related Cancer"},{"key":"1913_CR27","doi-asserted-by":"crossref","unstructured":"Mowrey K, Northrup H, Rougeau P, Hashmi SS, Krueger DA, Ebrahimi-Fakhari D, et al. Frequency, progression, and current management: report of 16 new cases of nonfunctional pancreatic neuroendocrine tumors in tuberous sclerosis complex and comparison with previous reports. Front Neurol. 2021;12:627672.","DOI":"10.3389\/fneur.2021.627672"},{"issue":"5159","key":"1913_CR28","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/bmj.2.5159.1065","volume":"2","author":"A Gutman","year":"1959","unstructured":"Gutman A, Leffkowitz M. Tuberous sclerosis associated with spontaneous hypoglycaemia. Br Med J. 1959;2(5159):1065\u20138.","journal-title":"Br Med J"},{"issue":"3","key":"1913_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/jcp.37.3.272","volume":"37","author":"EB Ilgren","year":"1984","unstructured":"Ilgren EB, Westmoreland D. Tuberous sclerosis: unusual associations in four cases. J Clin Pathol. 1984;37(3):272\u20138.","journal-title":"J Clin Pathol"},{"issue":"12","key":"1913_CR30","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/jnnp.55.12.1209","volume":"55","author":"PM Davoren","year":"1992","unstructured":"Davoren PM, Epstein MT. Insulinoma complicating tuberous sclerosis. J Neurol Neurosurg Psychiatry. 1992;55(12):1209.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"1913_CR31","first-page":"477","volume":"139","author":"G Schwarzkopf","year":"1994","unstructured":"Schwarzkopf G, Pfisterer J. [Metastasizing gastrinoma and tuberous sclerosis complex. Association or coincidence?]. Zentralbl Pathol. 1994;139(6):477\u201381.","journal-title":"Zentralbl Pathol"},{"issue":"7","key":"1913_CR32","first-page":"1543","volume":"16","author":"H Kim","year":"1995","unstructured":"Kim H, Kerr A, Morehouse H. The association between tuberous sclerosis and insulinoma. Am J Neuroradiol. 1995;16(7):1543\u20134.","journal-title":"Am J Neuroradiol"},{"issue":"4","key":"1913_CR33","first-page":"343","volume":"21","author":"NE Boubaddi","year":"1997","unstructured":"Boubaddi NE, Imbert Y, Tissot B, Chapus JJ, Dupont E, Gallouin D, et al. [Secreting insulinoma and Bourneville\u2019s tuberous sclerosis]. Gastroenterol Clin Biol. 1997;21(4):343.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"1913_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s004310051073","volume":"158","author":"S Verhoef","year":"1999","unstructured":"Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, Bax NMA, Ariyurek Y, Hermans CJ, et al. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatrics. 1999;158(4):284\u20137.","journal-title":"Eur J Pediatrics"},{"issue":"10","key":"1913_CR35","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/00000478-200310000-00012","volume":"27","author":"P Francalanci","year":"2003","unstructured":"Francalanci P, Diomedi-Camassei F, Purificato C, Santorelli FM, Giannotti A, Dominici C, et al. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol. 2003;27(10):1386\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"1913_CR36","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ajmg.a.31351","volume":"140A","author":"IIJL Merritt","year":"2006","unstructured":"Merritt IIJL, Davis DMR, Pittelkow MR, Babovic-Vuksanovic D. Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations. Am J Med Genet Part A. 2006;140A(15):1669\u201372.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"1913_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/PAS.0b013e31823d0560","volume":"36","author":"NC Arva","year":"2012","unstructured":"Arva NC, Pappas JG, Bhatla T, Raetz EA, Macari M, Ginsburg HB, et al. Well-differentiated pancreatic neuroendocrine carcinoma in Tuberous Sclerosis\u2014Case Report and Review of the literature. Am J Surg Pathol. 2012;36(1):149\u201353.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1913_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1066896911428735","volume":"20","author":"DD D\u00edaz","year":"2012","unstructured":"D\u00edaz DD, Ibarrola C, Sanz RG, Hurtado BP, Tabares JS, Ruizdelgado FC. Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis:a Case Report and Review of the literature. Int J Surg Pathol. 2012;20(4):390\u20135.","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"1913_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jpedsurg.2011.11.046","volume":"47","author":"M van den Akker","year":"2012","unstructured":"van den Akker M, Angelini P, Taylor G, Chami R, Gerstle JT, Gupta A. Malignant pancreatic tumors in children: a single-institution series. J Pediatr Surg. 2012;47(4):681\u20137.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"1913_CR40","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.4158\/EP13010.CR","volume":"19","author":"R Bombardieri","year":"2013","unstructured":"Bombardieri R, Moavero R, Roberto D, Cerminara C, Curatolo P. Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation. Endocr Pract. 2013;19(5):e124\u20138.","journal-title":"Endocr Pract"},{"issue":"2","key":"1913_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10689-017-0029-3","volume":"17","author":"P Mortaji","year":"2018","unstructured":"Mortaji P, Morris KT, Samedi V, Eberhardt S, Ryan S. Pancreatic neuroendocrine tumor in a patient with a TSC1 variant: case report and review of the literature. Fam Cancer. 2018;17(2):275\u201380.","journal-title":"Fam Cancer"},{"issue":"5","key":"1913_CR42","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ccr3.1483","volume":"6","author":"AN Comninos","year":"2018","unstructured":"Comninos AN, Yang L, Abbara A, Dhillo WS, Bassett JHD, Todd JF. Frequent falls and confusion: recurrent hypoglycemia in a patient with tuberous sclerosis complex. Clin Case Rep. 2018;6(5):904\u20139.","journal-title":"Clin Case Rep"},{"key":"1913_CR43","doi-asserted-by":"crossref","unstructured":"Amarjothi J, Jesudason J, Ramasamy V, Babu ON. Interesting pancreatic tumour in the background of tuberous sclerosis. BMJ Case Rep. 2019;12(8):e227292.","DOI":"10.1136\/bcr-2018-227292"},{"issue":"1","key":"1913_CR44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12876-020-01481-y","volume":"20","author":"LB Reis","year":"2020","unstructured":"Reis LB, Konzen D, Netto CBO, Braghini PMB, Prolla G, Ashton-Prolla P. Tuberous sclerosis complex with rare associated findings in the gastrointestinal system: a case report and review of the literature. BMC Gastroenterol. 2020;20(1):394.","journal-title":"BMC Gastroenterol."},{"issue":"11","key":"1913_CR45","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1016\/j.radcr.2021.08.041","volume":"16","author":"S Kopadze","year":"2021","unstructured":"Kopadze S, Shoshiashvili I, Dumbadze A, Tkemaladze T, Kiladze I. Neuroendocrine pancreatic tumor in a patient with dual diagnosis of tuberous sclerosis complex and basement membrane disease: a case report and review of the literature. Radiol Case Rep. 2021;16(11):3581\u20138.","journal-title":"Radiol Case Rep"},{"issue":"3","key":"1913_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.15537\/smj.2021.42.3.20200490","volume":"42","author":"MS Al Qahtani","year":"2021","unstructured":"Al Qahtani MS, Bojal SA, Alqarzaie AA, Alqahtani AA. Insulinoma in tuberous sclerosis: an entity not to be missed. Saudi Med J. 2021;42(3):332\u20137.","journal-title":"Saudi Med J"},{"key":"1913_CR47","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhong X, Lin X, Li X, Tian H, Chang B, et al. Tuberous sclerosis Complex with multiple organ tumors: Case Report and Literature Review. Front Oncol. 2022;12:916016.","DOI":"10.3389\/fonc.2022.916016"},{"issue":"3","key":"1913_CR48","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4183\/aeb.2022.350","volume":"18","author":"H Piskinpasa","year":"2022","unstructured":"Piskinpasa H, Dogansen SC, Metin D, Gumusoglu AY, Altinay S, Sipahi M, et al. Is there a relationship between tuberous sclerosis complex and insulinoma? Acta Endocrinol (Buchar). 2022;18(3):350\u20134.","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"2","key":"1913_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.gie.2008.04.057","volume":"69","author":"J Sreenarasimhaiah","year":"2009","unstructured":"Sreenarasimhaiah J, Armstrong LA, Tang S-J, Barnett C. Pancreatic somatostatinoma and tuberous sclerosis: case report of an exceedingly rare association. Gastrointest Endosc. 2009;69(2):379\u201381.","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"1913_CR50","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1210\/js.2017-00160","volume":"1","author":"MY Kang","year":"2017","unstructured":"Kang MY, Yeoh J, Pondicherry A, Rahman H, Dissanayake A. Insulinoma and Tuberous Sclerosis: a possible mechanistic target of Rapamycin (mTOR). Pathw Abnormality? J Endocr Soc. 2017;1(9):1120\u20133.","journal-title":"Pathw Abnormality? J Endocr Soc"},{"key":"1913_CR51","doi-asserted-by":"crossref","unstructured":"Librandi K, Grimaldi S, Catalano S, Moro F, Vallero SG, Spada M, et al. Insulinoma in pediatric tuberous sclerosis complex: a case report. Front Pead. 2023;11:1216201.","DOI":"10.3389\/fped.2023.1216201"},{"issue":"4","key":"1913_CR52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49(4):255\u201365.","journal-title":"Pediatr Neurol."},{"issue":"1","key":"1913_CR53","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1542\/peds.2010-0192","volume":"127","author":"BA Staley","year":"2011","unstructured":"Staley BA, Vail EA, Thiele EA. Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics. 2011;127(1):e117-25.","journal-title":"Pediatrics."},{"key":"1913_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0378-1119(03)00821-7","volume":"320","author":"M Ali","year":"2003","unstructured":"Ali M, Girimaji SC, Kumar A. Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog. Gene. 2003;320:145\u201354.","journal-title":"Gene"},{"issue":"2","key":"1913_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ejhg.2010.156","volume":"19","author":"AM van den Ouweland","year":"2011","unstructured":"van den Ouweland AM, Elfferich P, Zonnenberg BA, Arts WF, Kleefstra T, Nellist MD, et al. Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patients. Eur J Hum Genet. 2011;19(2):157\u201363.","journal-title":"Eur J Hum Genet"},{"issue":"13","key":"1913_CR56","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","volume":"14","author":"C Wilson","year":"2005","unstructured":"Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths DFR, Lazda E, et al. A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. Hum Mol Genet. 2005;14(13):1839\u201350.","journal-title":"Hum Mol Genet."}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01913-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01913-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01913-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T10:04:17Z","timestamp":1716804257000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01913-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01913-8","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has provided informed consent for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}